Mateja Krajc
Ljubljana, 1000, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Correction: Two recurrent pathogenic/likely pathogenic variants in PALB2 account for half of PALB2 positive families in Slovenia.
Journal: Human genomics
Published: April 30, 2026
Genetic testing for cancer predisposition syndromes in pediatric cancer patients: current practices and recommendations - a systematic review.
Journal: Radiology and oncology
Published: March 18, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.
Journal: NPJ breast cancer
Published: February 25, 2026
Importance of genetic testing in childhood cancer survivors for hereditary cancer predisposition syndromes.
Journal: Hereditary cancer in clinical practice
Published: February 08, 2026
Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
Journal: BJC reports
Published: November 14, 2025
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study.
Journal: European journal of human genetics : EJHG
Published: October 14, 2025
Implementing mainstream germline genetic testing in breast cancer across Europe.
Journal: BJC reports
Published: February 02, 2025
Last Updated: 09/26/2026